Skip to main content
OpenTrials

Clinical trial condition

Spinal Cord Diseases

Explore clinical trials studying Spinal Cord Diseases. Study availability and eligibility vary by location and protocol.

2,936 public trials 593 recruiting studies
Refine in advanced search Browse all conditions

Spinal Cord Diseases trial results

Completed

Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy

NCT02391831

Conditions
Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +10 more
Locations
  • Reference centre for neuromuscular diseases - UZ Leuven - Department of Pediatrics - University Hospitals Leuven Leuven, Belgium
  • Centre de Référence neuromusculaire - CHR La Citadelle Liège, Belgium
  • Service de Rééducation Pédiatrique Infantile " L'Escale " - Hôpital Femme Mère Enfant Bron, France
  • Maladie Neuromusculaire de l'enfant - Service Maladies infectieuses et neurologie infantile - Hôpital Roger Salengro Lille, France
View Trial Details
Completed

Bridge Reinvention

NCT03554733

Conditions
Behavior, Central Nervous System Diseases, Nervous System Diseases, +5 more
Locations
  • Craig Hospital Englewood, Colorado, United States
View Trial Details
Completed

Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine

NCT00635128

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
Locations
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
  • GSK Investigational Site Oberkirch, Baden-Wurttemberg, Germany
  • GSK Investigational Site Offenburg, Baden-Wurttemberg, Germany
View all 38 locations
View Trial Details
Completed

Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults

NCT01323959

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations
  • GSK Investigational Site Derval, France
  • GSK Investigational Site La Chapelle-Basse-Mer, France
  • GSK Investigational Site La Riche, France
  • GSK Investigational Site Nantes, France
View all 15 locations
View Trial Details
Completed

Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.

NCT00871000

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations
  • GSK Investigational Site Genoa, Liguria, Italy
  • GSK Investigational Site Milan, Lombardy, Italy
  • GSK Investigational Site Novara, Piedmont, Italy
  • GSK Investigational Site Cagliari, Sardinia, Italy
View Trial Details

Related conditions